Product Information
ROPINIROLE HCL 3 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0710 per EA under NDC 16729023601. Its NADAC has been published 301 times since Nov 14, 2018.
Strength
3 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729023601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
7/17/2024
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204022On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 3 MG TABLET has been published 301 times since Nov 14, 2018, and over the history we have for it it has declined 34.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0710 per EA |
|---|---|
| All-time high | $0.1151 (Sep 16, 2020) |
| All-time low | $0.0703 (Dec 22, 2021) |
| Median price | $0.0861 |
| Average price | $0.0888 |
| Largest weekly change | +39.8% (Dec 19, 2018) |
| Weeks tracked | 301 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 3 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0710 per EA (NDC 16729023601), effective Aug 14, 2024.
How has the price of ROPINIROLE HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 3 MG TABLET has declined 34.7%. It has been tracked across 301 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 3 MG TABLET?
Since Nov 14, 2018, the NADAC for ROPINIROLE HCL 3 MG TABLET has ranged from a low of $0.0703 (Dec 22, 2021) to a high of $0.1151 (Sep 16, 2020), with a median of $0.0861 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 3 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROPINIROLE HCL 3 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 3 MG TABLET?
ROPINIROLE HCL 3 MG TABLET (NDC 16729023601) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification